Orsiro: ultrathin bioabsorbable polymer sirolimus-eluting stent

Area of Science:

• Cardiovascular medicine
• Medical device technology
• Interventional cardiology

Background:

• Stent design innovations aim to minimize long-term inflammation.
• Bioresorbable polymers (BP) represent a key advancement in stent technology.
• Orsiro BP sirolimus-eluting stents are designed for improved clinical outcomes.

Purpose of the Study:

• To summarize clinical findings on Orsiro BP sirolimus-eluting stents.
• To discuss the established and potential benefits of Orsiro stents in clinical practice.
• To review evidence on the long-term safety and efficacy of Orsiro BP drug-eluting stents.

Main Methods:

• Systematic review of available clinical evidence.
• Analysis of clinical performance data for Orsiro BP sirolimus-eluting stents.
• Evaluation of comparative studies against other major drug-eluting stents.

Main Results:

• Orsiro BP sirolimus-eluting stents are clinically proven with a strong safety and efficacy profile.
• Demonstrated noninferiority compared to major drug-eluting stents in clinical trials.
• Long-term follow-up data support the sustained performance of Orsiro stents.

Conclusions:

• Orsiro BP sirolimus-eluting stents are a safe and effective treatment option.
• These stents may be particularly beneficial for specific patient subgroups, such as those with acute coronary syndrome.
• The BIOFLOW V trial provides evidence supporting Orsiro stents in acute coronary syndrome management.